Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma

Syngene International has announced the conclusion of the acquisition of a multi-modal biologics manufacturing facility from Stelis Biopharma as announced on 4 July 2023.

The acquisition of the ‘Unit 3’ biologics manufacturing facility was concluded at a revised gross value of Rs. 617 crore adjusted from the earlier gross value of Rs. 702 crore. The reduction in gross value reflects the retention of certain equipment not currently installed in the facility by Stelis Biopharma.

The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene. It also includes a commercial scale, high speed, fill-finish unit – an essential capability for drug product manufacturing. 

The Unit has been acquired effective 1st December, 2023 on payment of Rs. 395 crore. The balance, subject to final adjustments, will be paid in December 2023 on completion of certain post-closing actions by Stelis Biopharma.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!